Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Astrazeneca and Peregrine Pharma to collaborate on immuno-oncology combination clinical trial

Tuesday, August 25, 2015

Astrazeneca and Peregrine Pharmaceuticals to collaborate on immunooncology combination clinical trial Collaboration to evaluate safety and efficacy of Peregrines investigational phosphatidylserine pssignalling pathway inhibitor Bavituximab Planned...

Medivation to acquire Worldwide Rights to Talazoparib from BioMarin

Tuesday, August 25, 2015

Medivation Inc and BioMarin Pharmaceutical Inc said they have entered into an asset purchase agreement for Medivation to acquire all worldwide rights to talazoparib formerly referred to as BMN a highlypotent orallyavailable poly ADP ribose polymeras...

Regis Technologies opens Pharmaceutical Manufacturing Center in Morton Grove, Illinois

Saturday, August 22, 2015

Regis Technologies opened a new Potent Compound Suite for custom manufacturing of highly potent active pharmaceutical ingredients in Morton Grove Illinois The company spent two years constructing the suite and preparing its team for the new potent c...

Novartis buys remaining rights to GSK treatment for up to $1 billion

Friday, August 21, 2015

Novartis has agreed to buy all remaining rights to Ofatumumab from Britains GlaxoSmithKline for up to billion boosting the Swiss drugmakers stable of multiple sclerosis MS treatments Baselbased Novartis had previously acquired the rights to Ofatumu...

Lilly, Boehringer diabetes drug cuts heart attack, stroke risk in trial

Friday, August 21, 2015

A new diabetes pill from Eli Lilly and Co and Boehringer Ingelheim cut risk of heart attack stroke and death in a closely watched study the first glucoselowering drug to show such protective results in a large cardiovascular trial the drugmakers said...

Depomed rejects Horizon Pharma's offer for the third time

Thursday, August 20, 2015

Depomed Inc rejected Horizon Pharma Plcs HZNPO takeover bid for the third time reiterating that the offer undervalued the company Depomed said Horizon Pharmas latest allstock bid had a current value of per share or about billion lower than Horizon...

Denmark's Drug maker Lundbeck to cut 1,000 jobs in restructuring

Thursday, August 20, 2015

Drug maker Lundbeck will slash costs by billion Danish crowns million and cut jobs in a bid to regain profitability the company announced on Wednesday The Danish firm which appointed a new chief executive last May sells drugs to treat depression...

Amgen to pay $71 million to states for promoting off-label drug uses

Wednesday, August 19, 2015

Amgen Inc has agreed to pay million to settle allegations by state attorneys general that it improperly marketed two of its blockbuster drugs The agreement announced Tuesday brings an end to a difficult chapter in the history of the Thousand Oaks...

Veloxis Pharmaceuticals: Envarsus XR granted Orphan Drug status in the U.S

Tuesday, August 18, 2015

Veloxis Pharmaceuticals AS Said on Friday Envarsus XR was granted Orphan Drug status by the US Food and Drug Administration FDA for prophylaxis of organ rejection in patients who convert from immediaterelease tacrolimus Said looks forward to making...

India, EU working to end trade huff over generic drugs

Tuesday, August 18, 2015

India and the European Union are taking steps to end a trade row sparked by an EU ban on Indian pharmaceutical products that New Delhi responded to by cancelling talks on a free trade accord with its largest trading partner officials said Indian Pri...